BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Allurion Technologies to Initiate Clinical Study Combining Allurion Program with GLP-1 Therapy to Transform Obesity Care

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its ...

January 24, 2025 | News

Expecto Health Science Partners with Mayapada Hospital Jakarta Selatan to Strengthen Clinical Research in Asia-Pacific

Expecto Health Science, a leading full-service Contract Research Organization (CRO) in Asia Pacific with a focus on emerging economies, announced the signi...

January 24, 2025 | News

AIIB Launches Inaugural Health Strategy to Strengthen Resilient Health Systems Across Asia

The Asian Infrastructure Investment Bank (AIIB) launched its inaugural health strategy in December 2024, marking its first comprehensive str...

January 23, 2025 | News

Pearl Partners with Australia’s Centaur to Advance Dental AI Across Asia Pacific and Middle East

Pearl, the global leader in dental AI solutions, announced a strategic partnership with Centaur, Australia’s leading dental practice management ...

January 22, 2025 | News

Ascletis Pharma Reports Promising Results for ASC30 Oral Tablet in Obesity Treatment

ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose ...

January 22, 2025 | News

Junshi Biosciences Secures Australian Approval for Toripalimab, First Immuno-Oncology Treatment for Nasopharyngeal Carcinoma

Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...

January 21, 2025 | News

HKUST Researchers Develop World's Smallest Multifunctional Biomedical Robot for Precision Diagnosis and Treatment

Researchers from the School of Engineering of the Hong Kong University of Science and Technology (HKUST) have successfully developed the world's ...

January 21, 2025 | News

Guangzhou Fermion Partners with Simcere to Advance Clinical-Stage SSTR4 Agonist for Pain Management

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited have announced a partnership to develop a clinical-stage pain treatment ass...

January 20, 2025 | News

HALEO Partners with Munich Re Australia to Transform Disability Management Through Sleep Care

HALEO, a leader in virtual care for sleep disorders, is proud to announce a partnership with Munich Re Australia aimed at enhancing disability management t...

January 17, 2025 | News

IMPACT Therapeutics’ Senaparib Gains NMPA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer

IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthet...

January 17, 2025 | News

Nextbiomedical Secures FDA IDE Approval for U.S. Clinical Trial of Nexsphere-F™ in Knee Osteoarthritis

NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company in South Korea, proudly announced that it has received Investigational Devi...

January 16, 2025 | News

CMU Hosts International Forum Showcasing Taiwan’s Leadership in Extracellular Vesicle Technology

China Medical University (CMU) and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel Therapeutics to highligh...

January 16, 2025 | News

R-Bridge Healthcare Fund Provides $40M Financing to Mirxes to Accelerate Global Expansion of Cancer Early Detection Solutions

R-Bridge will provide bespoke financing of US$40 million with a synthetic royalty structure and f...

January 14, 2025 | News

Regor’s Oral GLP-1RA RGT-075 Shows 5% Placebo-Adjusted Weight Loss in Phase 2a Trial with Strong Safety Profile

Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a once-daily oral GLP-1RA, reporting 5% placebo-adjusted weight-loss with no ...

January 13, 2025 | News

Stay Connected